On December 13, 2022, more than 100 delegates attended the Ceremony of receiving the Decision for deploying the new technology and Scientific conference on applying TruScreen in cervical cancer screening.
In accordance with Circular 07/2015-BYT, a Pilot Project was implemented to apply TruScreen Optical-Electrical technology to cervical cancer screening for over a year. Up to now, the Ministry of Health has officially approved Tu Du Hospital to allow TruScreen to be used in medical examination and treatment at the hospital according to Decision No. 2691/QD-BYT dated October 3, 2022. The event marked the first successful step in transferring TruScreen Optical – Electrical technology to Tu Du Hospital – the leading unit in Obstetrics and Gynecology in the Vietnam Southern region.
At the ceremony, Specialist II Doctor Tran Ngoc Hai – Executive Deputy Director of Tu Du Hospital, expressed gratitude to the Ministry of Health and the leaders who supported the hospital in the process of new technical clinical practice steps. Besides, he emphasized the hospital’s determination to take the lead in women’s health care, especially focusing on screening and early detection of cervical cancer.
In addition, Ph.D. Tran Dang Khoa – Deputy Director of the Department of Maternal Health and Children, The Ministry of Health congratulated Tu Du Hospital on being officially deployed Truscreen – a new technology for cervical cancer screening and early detection. Ph.D. Tran Dang Khoa affirmed that this new technology is a milestone marking the hospital’s development in cervical cancer screening.
The next part, the hospital’s doctors presented reports about the application of TruScreen Optical-Electrical technology in cervical cancer screening, including: Specialist Doctor II Pham Thanh Hai – Deputy Director of Tu Du Hospital, and Specialist Doctor II Pham Ho Thuy Ai – Deputy Head of the Gynecological Examination Department.
The scientific reports provided information about Optical-Electrical method. Specifically, its sensitivity was estimated at 65.8% for LSIL, while it was 90.38% for HSIL and squamous cell carcinoma was up to 90.38%. Its specificity was estimated to be 78.89%.
The Optical-Electrical is evaluated as one of the effective cervical cancer screening methods in terms of the ability to detect CIN lesions early, limiting the miss of abnormal cases. The biggest advantage of this technology over other testing methods is that the results can be obtained immediately after the examination.
Furthermore, the lively discussion between experts provided useful information to attendees about the new Optical-Electrical method of screening cervical cancer. According to Ph.D.Tran Dang Khoa, Vietnam has about 4000 cervical cancer cases every year. Therefore, the implementation of the TruScreen Optical-Electrical technology at the hospital with low cost, non-invasiveness, fast and accurate results is a promising screening method in the near future.
Some more pictures of the event:
Newspapers reported on the event: